Drawing for TREZONOM

USPTO serial 85732632

TREZONOM

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
CANTONE, KERI H
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with TREZONOM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Maury M. Tepper, III

MAURY M. TEPPER, III TEPPER & EYSTER, PLLC3724 BENSON DRRALEIGH, NC 27609-7321UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005(Based on Intent to Use) Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceuticals, namely, anti-infectives (Based on 44(e) Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceuticals, namely, anti-infectivesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Mar 19, 2018MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 19, 2018ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 4, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 3, 2017EX5GSOU EXTENSION 5 GRANTED—
Jul 29, 2017EXT5SOU EXTENSION 5 FILED—
Jul 29, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 11, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 9, 2017EX4GSOU EXTENSION 4 GRANTED—
Feb 9, 2017EXT4SOU EXTENSION 4 FILED—
Feb 9, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 13, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 12, 2016EX3GSOU EXTENSION 3 GRANTED—
Aug 7, 2016EXT3SOU EXTENSION 3 FILED—
Aug 7, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 12, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 11, 2016EX2GSOU EXTENSION 2 GRANTED—
Mar 10, 2016AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Feb 9, 2016EXT2SOU EXTENSION 2 FILED—
Feb 9, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 6, 2015EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 4, 2015EX1GSOU EXTENSION 1 GRANTED—
Aug 4, 2015EXT1SOU EXTENSION 1 FILED—
Aug 4, 2015EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 10, 2015NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 16, 2014NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 16, 2014PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 26, 2014NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 12, 2014PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Nov 3, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 27, 2014RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Apr 14, 2014RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Sep 30, 2013RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Mar 19, 2013GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Mar 19, 2013GNSLLETTER OF SUSPENSION E-MAILED—
Mar 19, 2013CNSLSUSPENSION LETTER WRITTEN—
Mar 14, 2013TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 14, 2013CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 6, 2013ALIEASSIGNED TO LIE—
Mar 4, 2013TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 5, 2013GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 5, 2013GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 5, 2013CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 31, 2013TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 30, 2013CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 30, 2013ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Jan 17, 2013GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jan 17, 2013GNSLLETTER OF SUSPENSION E-MAILED—
Jan 17, 2013CNSLSUSPENSION LETTER WRITTEN—
Jan 16, 2013DOCKASSIGNED TO EXAMINER—
Sep 22, 2012NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 22, 2012NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance